510(k) K163591
K163591 is an FDA 510(k) premarket notification submitted by Becton, Dickinson And Company for the device "BD PosiFlush Heparin Lock Flush Syringe". The FDA issued a decision of Substantially Equivalent on Feb 27, 2017. The device falls under product code NZW (Heparin, Vascular Access Flush), a Class II device regulated under 21 CFR 880.5200. Becton, Dickinson And Company has 330 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 27, 2017
- Date Received
- Dec 20, 2016
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Heparin, Vascular Access Flush
- Device Class
- Class II
- Regulation Number
- 880.5200
- Review Panel
- HO
- Submission Type
- 510(k)
Enhance the performance of intravascular catheters, to maintain patency of the vascular catheter when it is not in use.
Need the full FDA record for Becton, Dickinson And Company? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.